Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Netilmicin 3mg/ml eye drops
1103010AMAAABAB
|
Netilmicin | Netilmicin (Eye) | Eye | No data available |
|
Nettacin 3mg/ml eye drops
1103010AMBBABAB
|
Nettacin | Netilmicin (Eye) | Eye | No data available |
|
Nettacin 3mg/ml eye drops 0.3ml unit dose
1103010AMBBAAAA
|
Nettacin | Netilmicin (Eye) | Eye | No data available |
|
Numark Hayfever 2% eye drops
1104020T0BVAAAA
|
Numark (Sodium cromoglicate) | Sodium cromoglicate | Eye | No data available |
|
Nyogel 0.1% eye gel
1106000Z0BGAAAR
|
Nyogel | Timolol | Eye | No data available |
|
Oculotect 5% eye drops 0.4ml unit dose
1108010T0BBAAAA
|
Oculotect | Povidone K 25 | Eye | No data available |
|
Ocutrop 1% eye drops
1105000B0BEAAAE
|
Ocutrop | Atropine sulfate | Eye | No data available |
|
Oftalmolosa Cusi Eritromicina 0.5% eye ointment
1103010I0BBAAAA
|
Oftalmolosa Cusi Eritromicina | Erythromycin | Eye | No data available |
|
Optrex Comforting eye dps 0.4ml unit dose preservative free
110402000BBAPA0
|
Proprietary compound preparation BNF 1104020 | Other anti-inflammatory preparations | Eye | No data available |
|
Optrex Infected Eyes 1% eye ointment
1103010C0BFABAD
|
Optrex (Chloramphenicol) | Chloramphenicol | Eye | No data available |
|
Optrex Red Eyes eye drops
1104020ABBCABAA
|
Optrex | Hamamalis | Eye | No data available |
|
Pegaptanib 300micrograms/0.09ml inj pre-filled syringes
1108020ACAAAAAA
|
Pegaptanib sodium | Pegaptanib sodium | Eye | No data available |
|
Phenylephrine 0.12% eye drops
1108010S0AAAAAA
|
Generic eye drops | Hypromellose with phenylephrine | Eye | No data available |
|
Phenylephrine 10% eye drops
1105000P0AAACAC
|
Phenylephrine hydrochloride (Eye) | Phenylephrine hydrochloride | Eye | No data available |
|
Phenylephrine 5.4mg/Tropicamide 0.28mg ophthalmic inserts
1105000T0AAAAAA
|
Phenylephrine hydrochloride/tropicamide (Eye) | Phenylephrine hydrochloride and tropicamide | Eye | No data available |
|
Pilocarpine hydrochloride 0.125% eye drops
1106000X0AAA3A3
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 0.25% eye drops
1106000X0AAAGAG
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 0.5% eye drops
1106000X0AABPBP
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 3% eye drops
1106000X0AAADAD
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 4% eye gel
1106000X0AABDBD
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 6% eye drops
1106000X0AAAIAI
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 6% eye drops preservative free
1106000X0AAA4A4
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine hydrochloride 8% eye drops
1106000X0AAARAR
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | No data available |
|
Pilocarpine nitrate 1% eye dps 0.5ml ud preservative free
1106000Y0AAAAAA
|
Pilocarpine nitrate | Pilocarpine nitrate | Eye | No data available |
|
Pilocarpine nitrate 4% eye dps 0.5ml ud preservative free
1106000Y0AAACAC
|
Pilocarpine nitrate | Pilocarpine nitrate | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.